Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

被引：0
|
作者：
Joaquín Casal
Margarita Amenedo
José Ramón Mel
Luis Miguel Antón
Rubén Rodríguez-López
Rafael López-López
Ana González-Ageitos
Javier Castellanos
Manuel Constenla
José L. Tisaire
机构：
[1] Hospital Do Meixoeiro,Medical Oncology Department
[2] Centro Oncológico de Galicia,Grupo Gallego de Cáncer de Pulmón (GGCP)
[3] Hospital Xeral Calde,undefined
[4] Hospital Juan Canalejo,undefined
[5] Hospital Sta Mª Madre,undefined
[6] Hospital Provincial de Santiago,undefined
[7] Hospital Povisa,undefined
[8] Hospital Xeral-Cíes,undefined
[9] Hospital Montecelo,undefined
[10] Aventis Pharma,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Gemcitabine; Docetaxel; NSCLC, first-line; Phase II;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：725 / 732
页数：7
相关论文
共 50 条
  • [1] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [2] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    CHEMOTHERAPY, 2012, 58 (01) : 78 - 83
  • [3] Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer
    Chiappori, A
    Simon, G
    Williams, C
    Haura, E
    Rocha-Lima, C
    Wagner, H
    Bepler, G
    Antonia, S
    ONCOLOGY, 2005, 68 (4-6) : 382 - 390
  • [4] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Sujith Kalmadi
    Giles McNeill
    Mellar Davis
    David Peereboom
    David Adelstein
    Tarek Mekhail
    Medical Oncology, 2006, 23 : 507 - 513
  • [5] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Kalmadi, Sujith
    McNeill, Giles
    Davis, Mellar
    Peereboom, David
    Adelstein, David
    Mekhail, Tarek
    MEDICAL ONCOLOGY, 2006, 23 (04) : 507 - 513
  • [6] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
  • [7] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    F Cappuzzo
    S Novello
    F De Marinis
    V Franciosi
    M Maur
    A Ceribelli
    V Lorusso
    F Barbieri
    L Castaldini
    E Crucitta
    L Marini
    S Bartolini
    G V Scagliotti
    L Crinò
    British Journal of Cancer, 2005, 93 : 29 - 34
  • [8] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    Cappuzzo, F
    Novello, S
    De Marinis, F
    Franciosi, V
    Maur, M
    Ceribelli, A
    Lorusso, V
    Barbieri, F
    Castaldini, L
    Crucitta, E
    Marini, L
    Bartolini, S
    Scagliotti, GV
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 29 - 34
  • [9] Biweekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2: A phase II study of the Galician Lung Cancer Group
    Vazquez-Estevez, S.
    Leon, L.
    Firvida, J. L.
    Grande, C.
    Vazquez, F.
    Salgado, M.
    Casal, J.
    Baron, F. J.
    Abal, J.
    Garcia, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] BIWEEKLY DOCETAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND PERFORMANCE STATUS (PS) 2. A PHASE II STUDY OF THE GALICIAN LUNG CANCER GROUP
    Leon, L.
    Vazquez Estevez, S.
    Firvida, J. L.
    Casal, J.
    Garcia, J.
    Salgado, M.
    Huidobro, G.
    Vazquez, F.
    Perez, E.
    Baron, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 95 - 95
12345